百濟神州科創板上市在即 戰略配售者陣容豪華
12月7日晚間,百濟神州有限公司公佈發行結果,網上投資者繳款認購數約為4,038.70萬股,認購資金約為77.78億元;網下投資者認購5,637.72萬股,認購資金約為108.58億元。
其中網下投資者全額認購,而僅有部分網上投資者選擇棄購。數據顯示,網上投資者放棄認購數量為103.25萬股,投資者棄購的部分將主要由中金公司包銷。若按公司發行股份數量1.15億股計算,整體棄購率僅為0.90%。
值得一提的是,百濟神州本次發行引入了“綠鞋”機制,已授予中金公司為期30日的超額配售選擇權,可超額配售不超過1,725.80萬股人民幣股份。如超額配售選擇權被全部行使,則百濟神州本次科創板發行的總股數為1.32億股,佔百濟神州截至2021年10月31日已發行股份總數及本次公開發行股份數量之和的9.79%(超額配售選擇權全額行使後)。
此外,百濟神州科創板IPO戰略配售者陣容也十分“豪華”,社保基金、中國保險投資基金(有限合夥)、中央企業鄉村產業投資基金股份有限公司、阿布達比投資局等多家知名機構均有參與。


數據來源:百濟神州科創板發行公吿
同時,百濟神州也是知名投資機構高瓴美股持倉市值中的第一大重倉股,在港股市場上高瓴也同樣重倉百濟神州。截至2021年三季度末,高瓴在美股、港股兩個市場持股近1.47億股(美股ADR換算成港股普通股),持股比例約為12%。
此次如登陸科創板後,百濟神州將成為全球首家在上交所、納斯達克、港交所三地上市的生物科技公司。根據發行結果公吿,百濟神州此次科創板發行定價192.60元/股,發行股份總數為普通股115,055,260股,預計募集資金總額221.60億元;如超額配售選擇權被全部行使,則本次科創板發行的總股數為132,313,260股,募集資金可達254.84億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.